MedTrace Logo

Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems

NCT03918070 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2722

Last updated 2024-05-08

No results posted yet for this study

Summary

The TRANSLUMINA GmbH YuChooSeR Observatory is a prospective, multicentric post-marketing observatory designed to evaluate large scale safety and reliability of the Yukon Choice PC and the Yukon Chrome PC stents systems use in routine, clinical practice.

This based observatory will enroll 3000 patients to 30 sites in France.

Conditions

  • Coronaropathy

Interventions

DEVICE

Yukon Choice PC and Yukon Chrome PC

The Yukon Choice PC \& the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Coronary Stent Systems are indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease.

Sponsors & Collaborators

  • EVAMED

    collaborator OTHER

  • Translumina GmbH

    lead INDUSTRY

Principal Investigators

  • Didié Tchétché, Dr · Clinique Pasteur

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2024-04-24
Completion
2024-05-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03918070 on ClinicalTrials.gov